DE102011114411A1 - Pflaster mit einstellbarer Okklusion - Google Patents

Pflaster mit einstellbarer Okklusion Download PDF

Info

Publication number
DE102011114411A1
DE102011114411A1 DE102011114411A DE102011114411A DE102011114411A1 DE 102011114411 A1 DE102011114411 A1 DE 102011114411A1 DE 102011114411 A DE102011114411 A DE 102011114411A DE 102011114411 A DE102011114411 A DE 102011114411A DE 102011114411 A1 DE102011114411 A1 DE 102011114411A1
Authority
DE
Germany
Prior art keywords
transdermal
patch according
topical patch
polymer
water vapor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE102011114411A
Other languages
German (de)
English (en)
Inventor
Walter Müller
Patrick Mohr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Priority to DE102011114411A priority Critical patent/DE102011114411A1/de
Priority to BR112014007210-8A priority patent/BR112014007210B1/pt
Priority to IN2984CHN2014 priority patent/IN2014CN02984A/en
Priority to MX2014003669A priority patent/MX338901B/es
Priority to ES12762597T priority patent/ES2755728T3/es
Priority to EP12762597.8A priority patent/EP2760436B1/de
Priority to RU2014116821A priority patent/RU2616524C2/ru
Priority to CN201710819641.3A priority patent/CN107595818A/zh
Priority to CN201280046758.8A priority patent/CN103826619A/zh
Priority to JP2014531268A priority patent/JP6033309B2/ja
Priority to US14/346,527 priority patent/US9180103B2/en
Priority to KR1020147011086A priority patent/KR101945573B1/ko
Priority to AU2012314560A priority patent/AU2012314560C1/en
Priority to PCT/EP2012/068828 priority patent/WO2013045420A1/de
Priority to CA2849956A priority patent/CA2849956C/en
Publication of DE102011114411A1 publication Critical patent/DE102011114411A1/de
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/48—Surfactants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE102011114411A 2011-09-26 2011-09-26 Pflaster mit einstellbarer Okklusion Withdrawn DE102011114411A1 (de)

Priority Applications (15)

Application Number Priority Date Filing Date Title
DE102011114411A DE102011114411A1 (de) 2011-09-26 2011-09-26 Pflaster mit einstellbarer Okklusion
BR112014007210-8A BR112014007210B1 (pt) 2011-09-26 2012-09-25 Emplastro com oclusão reajustável
IN2984CHN2014 IN2014CN02984A (https=) 2011-09-26 2012-09-25
MX2014003669A MX338901B (es) 2011-09-26 2012-09-25 Parche con oclusion ajustable.
ES12762597T ES2755728T3 (es) 2011-09-26 2012-09-25 Parche con oclusión ajustable
EP12762597.8A EP2760436B1 (de) 2011-09-26 2012-09-25 Pflaster mit einstellbarer okklusion
RU2014116821A RU2616524C2 (ru) 2011-09-26 2012-09-25 Пластырь с регулируемой окклюзией
CN201710819641.3A CN107595818A (zh) 2011-09-26 2012-09-25 具有可调节封闭性的贴剂
CN201280046758.8A CN103826619A (zh) 2011-09-26 2012-09-25 具有可调节封闭性的贴剂
JP2014531268A JP6033309B2 (ja) 2011-09-26 2012-09-25 調節可能な閉塞を有するプラスター
US14/346,527 US9180103B2 (en) 2011-09-26 2012-09-25 Plaster having adjustable occlusion
KR1020147011086A KR101945573B1 (ko) 2011-09-26 2012-09-25 조절가능한 폐색을 갖는 플라스터
AU2012314560A AU2012314560C1 (en) 2011-09-26 2012-09-25 Plaster having adjustable occlusion
PCT/EP2012/068828 WO2013045420A1 (de) 2011-09-26 2012-09-25 Pflaster mit einstellbarer okklusion
CA2849956A CA2849956C (en) 2011-09-26 2012-09-25 Plaster having adjustable occlusion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102011114411A DE102011114411A1 (de) 2011-09-26 2011-09-26 Pflaster mit einstellbarer Okklusion

Publications (1)

Publication Number Publication Date
DE102011114411A1 true DE102011114411A1 (de) 2013-03-28

Family

ID=46924436

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102011114411A Withdrawn DE102011114411A1 (de) 2011-09-26 2011-09-26 Pflaster mit einstellbarer Okklusion

Country Status (14)

Country Link
US (1) US9180103B2 (https=)
EP (1) EP2760436B1 (https=)
JP (1) JP6033309B2 (https=)
KR (1) KR101945573B1 (https=)
CN (2) CN103826619A (https=)
AU (1) AU2012314560C1 (https=)
BR (1) BR112014007210B1 (https=)
CA (1) CA2849956C (https=)
DE (1) DE102011114411A1 (https=)
ES (1) ES2755728T3 (https=)
IN (1) IN2014CN02984A (https=)
MX (1) MX338901B (https=)
RU (1) RU2616524C2 (https=)
WO (1) WO2013045420A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023079119A1 (de) * 2021-11-05 2023-05-11 Lts Lohmann Therapie-Systeme Ag Okklusives pflaster mit flexibler backing
WO2023079118A1 (de) * 2021-11-05 2023-05-11 Lts Lohmann Therapie-Systeme Ag Diclofenac enthaltendes tts mit dimethylpropylenharnstoff

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170136124A1 (en) * 2015-11-16 2017-05-18 Noven Pharmaceuticals, Inc. Stretchable backing layers for transdermal drug delivery systems
BR112019007325A2 (pt) * 2016-10-18 2019-07-02 Lts Lohmann Therapie Systeme Ag sistema terapêutico tópico de duas camadas
EP3384904A1 (en) 2017-04-03 2018-10-10 tesa Labtec GmbH Pharmaceutical preparation for dermal administration
RU2705896C1 (ru) * 2019-07-26 2019-11-12 Артем Олегович Бахметьев Трансдермальный пластырь
DE102020107937A1 (de) * 2020-03-23 2021-09-23 Lts Lohmann Therapie-Systeme Ag DMEH - Enhancer

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235306B1 (en) 1991-06-27 2001-05-22 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE10027258C1 (de) * 2000-05-31 2001-10-31 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit okklusiver wirkstoffhaltiger Schicht und nicht-okklusiver Rückschicht
EP1366762A1 (en) * 2001-03-07 2003-12-03 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
DE102006019293A1 (de) * 2006-04-21 2007-10-25 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Pflaster, enthaltend ein Fentanyl Analogum
EP2042174A1 (en) * 2006-07-14 2009-04-01 Hisamitsu Pharmaceutical Co., Inc. Adhesive preparation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
US4814168A (en) * 1988-03-04 1989-03-21 Noven Pharmaceuticals, Inc. Transdermal multipolymer drug delivery system
CN1151780C (zh) * 1993-01-02 2004-06-02 诺纹制药股份有限公司 基于溶度参数的药物释放系统和改变药物饱和浓度的方法
DE10060550C1 (de) * 2000-12-06 2002-04-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Oxybutynin und Verfahren zur Herstellung Oxybutynin enthaltender Wirkstoffschichten
DE10103860B4 (de) * 2001-01-30 2004-12-23 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
CN1950309B (zh) 2004-05-07 2010-11-24 旭硝子株式会社 单层密封型复层透明体及其制造方法
DE102006054733A1 (de) * 2006-11-21 2008-05-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235306B1 (en) 1991-06-27 2001-05-22 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE10027258C1 (de) * 2000-05-31 2001-10-31 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit okklusiver wirkstoffhaltiger Schicht und nicht-okklusiver Rückschicht
WO2001091718A2 (de) 2000-05-31 2001-12-06 Lts Lohmann Therapie-Systeme Ag Okklusives transdermales therapeutisches system mit nicht-okklusiver rückschicht
EP1366762A1 (en) * 2001-03-07 2003-12-03 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
DE102006019293A1 (de) * 2006-04-21 2007-10-25 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Pflaster, enthaltend ein Fentanyl Analogum
EP2042174A1 (en) * 2006-07-14 2009-04-01 Hisamitsu Pharmaceutical Co., Inc. Adhesive preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DIN-Methode EN 13726-2

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023079119A1 (de) * 2021-11-05 2023-05-11 Lts Lohmann Therapie-Systeme Ag Okklusives pflaster mit flexibler backing
WO2023079118A1 (de) * 2021-11-05 2023-05-11 Lts Lohmann Therapie-Systeme Ag Diclofenac enthaltendes tts mit dimethylpropylenharnstoff

Also Published As

Publication number Publication date
BR112014007210B1 (pt) 2021-12-21
CA2849956A1 (en) 2013-04-04
MX338901B (es) 2016-05-03
CN103826619A (zh) 2014-05-28
US9180103B2 (en) 2015-11-10
CA2849956C (en) 2019-09-03
KR101945573B1 (ko) 2019-02-07
KR20140072128A (ko) 2014-06-12
AU2012314560A1 (en) 2014-05-15
RU2616524C2 (ru) 2017-04-17
US20140234395A1 (en) 2014-08-21
CN107595818A (zh) 2018-01-19
JP6033309B2 (ja) 2016-11-30
ES2755728T3 (es) 2020-04-23
RU2014116821A (ru) 2015-11-10
BR112014007210A2 (pt) 2017-04-04
IN2014CN02984A (https=) 2015-07-03
MX2014003669A (es) 2014-04-30
EP2760436B1 (de) 2019-09-18
JP2014526546A (ja) 2014-10-06
AU2012314560C1 (en) 2016-10-06
WO2013045420A1 (de) 2013-04-04
AU2012314560B2 (en) 2016-02-18
EP2760436A1 (de) 2014-08-06

Similar Documents

Publication Publication Date Title
EP2760436B1 (de) Pflaster mit einstellbarer okklusion
EP1094796B1 (de) Topisches pflaster mit nichtsteroidalen antirheumatika mit säuregruppe
EP2468274B1 (de) Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs
EP1171104A2 (de) Transdermales therapeutisches system mit neutralisierten acrylhaftklebern
DE69508342T2 (de) Zusammensetzung zur perkutan Absorption
DE10212864B4 (de) Polymermatrizes umfassend ein Mischsystem zur Löslichkeitsvermittlung von pharmazeutischen Wirkstoffen, Verfahren zu deren Herstellung und deren Verwendung
EP2111857A1 (de) Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff hiervon
EP1782799A2 (de) Transdermales therapeutisches System mit Fentanylanalogen Wirkstoffen
EP1284718B1 (de) Okklusives transdermales therapeutisches system mit nicht-okklusiver rückschicht
EP1335713A2 (de) Flexible barrierefolie für ein trägermaterial für medizinische zwecke
DE102006019293A1 (de) Pflaster, enthaltend ein Fentanyl Analogum
DE102006026060B4 (de) Transdermales Therapeutisches System enthaltend als Wirkstoff Nikotin und Verfahren zur Herstellung solcher Systeme
WO1998034600A1 (de) Dehnbares transdermales therapeutisches system
WO2002038134A2 (de) Mehrschichtige trägerkonstruktion für wirkstoffhaltige pflastersysteme
EP3713549A1 (de) Transdermales therapeutisches system auf basis von klebenden weichmacher-polymer-matrices
EP4426273A1 (de) Okklusives pflaster mit flexibler backing
EP2366388A1 (de) Nicht-okklusives transdermales therapeutisches System zur Verabreichung von Buprenorphin
DE102008006791B4 (de) Transdermales Therapeutisches System mit Harnstoff-Komponente und Verfahren zu dessen Herstellung
EP0742716A1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
DE69803607T2 (de) Zusammensetzungen zur transdermalen und dermalen verabreichung von biologisch wirksamen stoffen
DE102018216244A1 (de) Transdermales therapeutisches System mit Barriereschicht
EP3697394A1 (de) Transdermales darreichungssystem enthaltend einen dopaminagonisten
DE102017115701B4 (de) Fampridin-TTS
DE112024000733T5 (de) Transdermales therapeutisches system zur transdermalen verabreichung von huperzin a
WO2014198422A1 (de) Transdermales therapiesystem (tts) mit rotigotin

Legal Events

Date Code Title Description
R012 Request for examination validly filed
R016 Response to examination communication
R120 Application withdrawn or ip right abandoned